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SI/CTR Abstract 
Survivorship, Complications, and Outcomes Following Distal Femoral Replacement 
Using Megaprosthesis 
Keenan Sobol BS, John Strony BS, Timothy Tan MD, Scot Brown MD* 
 
Introduction 
Distal femoral bone loss is often managed with a combination of modular prostheses, 
structural and non-structural allografts, and metal augmentation. However, when bone 
loss of the distal femur is severe, the viability of these methods can be limited. In the 
setting of severe bone loss, endoprosthetic reconstruction (EPR) with a megaprosthesis 
has become increasingly popular for both malignant and non-neoplastic indications. The 
primary aim of this study was to determine the short-term prosthesis survivorship, as well 
as complications, for patients who presented with non-neoplastic disease indications for 
megaprosthesis distal femoral replacement (DFR) at a single institution. The secondary 
aim was to identify factors that influenced the outcome of DFR. 
Methods  
A retrospective review was performed to identify patients who underwent megaprosthetic 
DFR surgery for a non-neoplastic indication, including native and preiprosthetic 
fractures, septic and aseptic nonunion, periprosthetic joint infection (PJI), and aseptic 
loosening or mechanical failure of a previous prosthesis. Information regarding 
complications, reoperations, demographics and comorbidities were recorded, excluding 
patients with less than 24 months follow-up. Reoperation for implant failure was used as 
the final endpoint for survivorship. 
Results  
Seventy-five patients were identified. DFR survivorship was 86% at one year and 76% at 
five years. Patients who sustained a native fracture or had non-union demonstrated the 
highest survival rate at one and five years, (91%, 82% respectively) followed by patients 
with aseptic loosening or mechanical failure of previous implants, and then patients with 
PJI. A total of 36 (48 %) patients experienced at least one post-operative complication 
and 27 patients (36%) required at least one reoperation. Fracture, aseptic loosening, and 
PJI were complications more likely to require reoperation for prosthesis failure. 
Furthermore, patient demographics and comorbidities were not significant for predicting 
failure. 
Discussion 
DFR is a viable surgical option for significant distal femoral bone loss with good short-
term survivorship. There is a high overall complication rate, however the complication 
profile, as well as survivorship may vary based on the initial indication for DFR. 
 
 
 
